Latest Period
Q1 2026
Security Snapshot
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) Institutional Ownership
CUSIP: 91864C107
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
14
Shares (Excl. Options)
9,297,185
Price
$0.57
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / American Depositary Shares, each representing one ordinary share
- Symbol
- BRNS on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 9,297,185
- Total 13F value
- $7,887,406
- Portfolio coverage rank
- 0%
- Share change
- +151,983
- Value change
- +$86,286
- Number of holders
- 14
- Shares outstanding
- 40,291,821
- SEC-reported price per share
- $0.70
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share is tracked under CUSIP 91864C107.
- 14 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 12 to 14 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $6,096,264 to $7,887,406.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 14 institutions filings for Q1 2026.
Security key
91864C107
Latest holder period
Q1 2026
13F holders
14
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
BRNS full holder history
Barinthus Biotherapeutics plc. SEC filings
Barinthus Biotherapeutics plc. company facts
Barinthus Biotherapeutics plc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 91864C107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
BRNS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cawood Frank Wayne | 8.4% | $3,384,513 | 3,384,513 | Frank W. Cawood | 31 Dec 2024 |
As of 31 Mar 2026, 14 institutional investors reported holding 9,297,185 shares of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS). This represents 23% of the company’s total 40,291,821 outstanding shares.
13F concentration
Top 15 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| M&G PLC | 13% | 5,197,349 | 0% | 0.03% | $5,197,349 |
| HSG Holding Ltd | 3.5% | 1,420,473 | 0% | 0.08% | $1,164,788 |
| GLR Partners, LLC | 3.1% | 1,243,377 | 0% | 0.39% | $707,482 |
| DC Funds, LP | 1.6% | 642,204 | 0% | 25% | $365,414 |
| Rangeley Capital, LLC | 0.4% | 159,465 | +89% | 0.1% | $90,736 |
| RENAISSANCE TECHNOLOGIES LLC | 0.37% | 151,000 | +5.5% | 0% | $85,919 |
| Johns Hopkins University | 0.3% | 122,237 | 0% | 0.01% | $69,553 |
| CITADEL ADVISORS LLC | 0.3% | 118,996 | +0.17% | 0% | $68,125 |
| Baird Financial Group, Inc. | 0.26% | 105,961 | 0% | 0% | $60,292 |
| GTS SECURITIES LLC | 0.18% | 73,210 | 0% | $41,876 | |
| HighTower Advisors, LLC | 0.09% | 37,450 | 0% | 0% | $21,309 |
| RHUMBLINE ADVISERS | 0.03% | 11,685 | 0% | 0% | $6,683 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.03% | 11,568 | 0% | 0% | $6,622 |
| MORGAN STANLEY | 0.01% | 2,210 | -35% | 0% | $1,258 |
| UBS Group AG | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 9,297,185 | $7,887,406 | +$86,286 | $0.57 | 14 |
| 2025 Q4 | 6,481,352 | $6,096,264 | -$1,748,009 | $0.70 | 12 |
| 2025 Q3 | 9,172,174 | $10,350,135 | -$134,698 | $1.25 | 15 |
| 2025 Q2 | 9,309,661 | $9,021,053 | -$163,257 | $0.93 | 14 |
| 2025 Q1 | 9,485,402 | $9,148,082 | -$234,186 | $0.97 | 14 |
| 2024 Q4 | 9,717,331 | $10,336,336 | -$702,886 | $1.21 | 16 |
| 2024 Q3 | 9,686,533 | $10,740,001 | -$279,458 | $1.19 | 19 |
| 2024 Q2 | 9,914,647 | $11,759,119 | +$303,322 | $1.40 | 18 |
| 2024 Q1 | 9,698,209 | $21,348,890 | -$47,421 | $2.38 | 15 |
| 2023 Q4 | 9,718,135 | $36,531,700 | +$41,711 | $3.69 | 15 |
| 2023 Q3 | 9,706,658 | $29,525,600 | -$281,231 | $3.09 | 16 |
| 2023 Q2 | 9,847,143 | $19,972,820 | -$752,585 | $2.06 | 15 |
| 2023 Q1 | 10,208,776 | $21,620,956 | -$48,614 | $2.24 | 13 |
| 2022 Q4 | 10,228,507 | $22,244,733 | +$312,161 | $2.35 | 15 |
| 2022 Q3 | 10,095,963 | $31,249,000 | +$10,999,294 | $3.20 | 11 |
| 2022 Q2 | 6,298,127 | $27,536,000 | +$7,434,957 | $4.45 | 12 |
| 2022 Q1 | 4,627,371 | $23,843,000 | -$1,912,073 | $5.20 | 10 |
| 2021 Q4 | 4,901,592 | $54,334,000 | -$2,208,184 | $11.11 | 14 |
| 2021 Q3 | 4,927,049 | $67,494,108 | -$4,976,210 | $15.74 | 15 |
| 2021 Q2 | 3,987,438 | $66,015,000 | +$66,015,000 | $16.78 | 18 |